Kyle Bass: The U.S. Still Has A Drug Problem

To date, the Patent Trial and Appeal Board has reached a final decision in eight instituted inter partes review (IPR) challenges, including seven IPRs filed by the Coalition for Affordable Drugs and one IPR filed by Erich Spangenberg and me personally on a not-for-profit basis. The outcomes were favorable in seven of the eight IPRs. Our…


Comments are closed.

Biotechblog